Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom. It has raised $50M in total funding. Latest round: Growth. Backed by Akeso, Inc..
Summit Therapeutics funding overview
Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom. Summit Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in December 2019. The round record for Summit Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Akeso, Inc..
Summit Therapeutics at a glance
Total raised
$50M
Latest round
Growth
Latest round date
December 2019
Headquarters
Abingdon, Oxfordshire, United Kingdom
Notable investors
Akeso, Inc.
Frequently asked about Summit Therapeutics funding
How much has Summit Therapeutics raised?
Summit Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Summit Therapeutics?
Akeso, Inc. are named among the investors backing Summit Therapeutics.
What was the latest Summit Therapeutics funding round?
The most recent disclosed round is a Growth, announced in December 2019.
Where is Summit Therapeutics based?
Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom.
When did Summit Therapeutics last raise?
The last disclosed Summit Therapeutics round closed in December 2019 at Growth.
Round data for Summit Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Abingdon and backer lists below.
